Tevogen Bio Holdings Stock Performance
| TVGN Stock | 1.20 0.12 9.09% |
The entity has a beta of -0.87, which indicates possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Tevogen Bio are expected to decrease slowly. On the other hand, during market turmoil, Tevogen Bio is expected to outperform it slightly. Tevogen Bio Holdings right now has a risk of 7.52%. Please validate Tevogen Bio semi variance, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Tevogen Bio will be following its existing price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Over the last 90 days Tevogen Bio Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Tevogen Bio is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 129.2 K |
Tevogen |
Tevogen Bio Relative Risk vs. Return Landscape
If you would invest 137.00 in Tevogen Bio Holdings on November 27, 2024 and sell it today you would lose (17.00) from holding Tevogen Bio Holdings or give up 12.41% of portfolio value over 90 days. Tevogen Bio Holdings is currently generating 0.0462% in daily expected returns and assumes 7.5239% risk (volatility on return distribution) over the 90 days horizon. In different words, 67% of stocks are less volatile than Tevogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tevogen Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tevogen Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tevogen Bio Holdings, and traders can use it to determine the average amount a Tevogen Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0061
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TVGN |
Estimated Market Risk
| 7.52 actual daily | 67 67% of assets are less volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tevogen Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tevogen Bio by adding Tevogen Bio to a well-diversified portfolio.
Tevogen Bio Fundamentals Growth
Tevogen Stock prices reflect investors' perceptions of the future prospects and financial health of Tevogen Bio, and Tevogen Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tevogen Stock performance.
| Return On Asset | -5.42 | ||||
| Current Valuation | 255.13 M | ||||
| Shares Outstanding | 175.05 M | ||||
| EBITDA | 188.71 K | ||||
| Total Debt | 1.63 M | ||||
| Book Value Per Share | (0.08) X | ||||
| Cash Flow From Operations | (1.38 M) | ||||
| Earnings Per Share | 0.35 X | ||||
| Total Asset | 17.04 M | ||||
| Retained Earnings | (17.38 M) | ||||
About Tevogen Bio Performance
By examining Tevogen Bio's fundamental ratios, stakeholders can obtain critical insights into Tevogen Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Tevogen Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Tevogen Bio Holdings performance evaluation
Checking the ongoing alerts about Tevogen Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tevogen Bio Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tevogen Bio Holdings had very high historical volatility over the last 90 days | |
| Tevogen Bio Holdings may become a speculative penny stock | |
| Net Loss for the year was (67.33 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tevogen Bio generates negative cash flow from operations | |
| Tevogen Bio Holdings has a frail financial position based on the latest SEC disclosures | |
| About 92.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Tevogen Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tevogen Bio's stock is overvalued or undervalued compared to its peers.
- Examining Tevogen Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tevogen Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tevogen Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tevogen Bio's stock. These opinions can provide insight into Tevogen Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.